TSHR and obesity disorder: The thyrotropin receptor (TR) agonist-mediated induction of browning may be a treatment-appropriate strategy for obesity, and treatment with the TR agonist GC-1 promotes WAT browning and reduces obesity and diabetes in mice [67].